product image
In the fight against COVID-19 – Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit

Apr 14, 2020

Eli Lilly has announced to begin clinical trials of rheumatoid arthritis drug Olumiant to treat COVID-19 patients.  The company plans to explore the anti-inflammatory ...

Read More
product image
Is Hydroxychloroquine the answer to all the COVID-19 questions?

Apr 17, 2020

Amid the political debate, the US NIH has last week begun the clinical trials of the malarial drug hydroxychloroquine to test its efficacy and safety in patients with COVID...

Read More
product image
AstraZeneca targets for COVID-19 antibody trial; Arrakis, Roche team up; GSK, AstraZeneca launch testing lab, U.S. government funds OraSure

Apr 9, 2020

AstraZeneca aims for summer start for COVID-19 antibody trial AstraZeneca has made its multipronged approach to the development of antibodies against the pandemic SARS-CoV-...

Read More
product image
COVID-19 crisis can prove to be a catalyst for Artificial Intelligence in Healthcare

Apr 8, 2020

The novel coronavirus (COVID-19) within a span of five months, has infected around 1 million people, resulting in deaths of 50,000 people in over 180 countries around the w...

Read More
product image
Immunomedics Halts Sacituzumab govitecan trial; GSK-Vir Biotech collaboration; INO-4800 DNA COVID-19 Vaccine; Pfizer Commits $ 40M for COVID-19

Apr 17, 2020

Immunomedics discontinues its trial early – hopes for accelerated approval of Sacituzumab govitecan for mTNBC Immunomedics– a New Jersey-based pharmaceutical compan...

Read More
product image
World Health Day

Apr 7, 2020

Today, 7 April, is World Health Day. While the world is waging war against COVID-19, let us take a moment to be grateful to the emergency stuff- Doctors, Heath workers, Nur...

Read More
product image
Warm Autoimmune Hemolytic Anemia: A less prevalent disease with prevailing unmet needs

Apr 13, 2020

Warm Autoimmune Hemolytic Anemia market is anticipated to increase with a CAGR of 15.9% in the 7MM by 2030, estimates DelveInsight. In 2017, as per the estimates by DelveIn...

Read More
product image
Warm Autoimmune Hemolytic Anemia Epidemiology forecast segmentation, treatment approaches, and WAIHA market forecast

Apr 13, 2020

As per DelveInsight’s Warm Autoimmune Hemolytic anemia Epidemiology forecast and analysis, WAIHA prevalence in the 7MM was estimated to be around 82,045 cases. Autoimmune...

Read More
product image
Niacin fights Glioblastoma, iTeos nets $125M, Pandion reels in $80M, Brii, Chinese partner, FDA to speed up COVID-19 therapies

Apr 23, 2020

Niacin might help in combating Glioblastoma  Glioblastomas are difficult to treat in part as the brain’s immune cells are stifled and unable to attack against tumors...

Read More
product image
Telemedicine: Can it be the future of healthcare?

Jun 30, 2020

Telemedicine is one of the fastest-growing domains in the healthcare industry. Telemedicine is the practice of providing healthcare services like evaluation, diagnosis and ...

Read More
product image
J&J’s COVID-19 Vaccine; GigaGen COVID-19 therapy; FDA approved Abbott’s POC test; Cobra Bio raises $ 3.3 M

Apr 23, 2020

Johnson & Johnson is fast-forwarding its vaccine development program for COVID-19.  The healthcare company has selected a lead vaccine candidate and is planning to...

Read More
product image
Realm of Pandemics: Were we prepared then? Are we prepared now? Will we be ever prepared?

Apr 13, 2020

COVID-19, a novel coronavirus after toppling down China, has managed to create havoc in the entire world, with people fearing the impending doom.  This is no news that...

Read More
product image
What is driving Retinitis pigmentosa market forward?

Jun 30, 2020

DelveInsight estimates an increase in Retinitis Pigmentosa Market Size during the study period 2017–2030, from USD 237.27 million, as reported in 2017 in the 7MM. The inc...

Read More
product image
FDA permits COVID-19 treatment, Roche’s antibiotics pact, Moderna’s vaccine, FDA permits Remdesivir, ReCode needs USD 80 Million

Mar 26, 2020

FDA permits COVID-19 treatments with blood from survivors The FDA revealed the convalescent plasma use that is derived from the donated blood of people that have recovered ...

Read More
product image
Bioelectronic Medicine: Applications and Future Prospects

Jun 26, 2020

Healthcare industry during the past few decades has witnessed phenomenal growth and improvement due to technological advancement and innovation. The hospital management, me...

Read More